动力学和机械释放研究对氨水凝进行研究,以了解它们作为响应pH的药物输送装置的潜在用途
Saliha Erikci1,2, Niklas van den Bergh1,3, Heike Boehm1,4
1Department of Cellular Biophysics, Max Planck Institute for Medical Research, 69120 Heidelberg, Germany.
Gels (Basel, Switzerland)
|November 26, 2024
概括
硫化氨酸水凝显示可调节的药物释放特性,以响应pH值的变化. 这种pH敏感的药物输送系统对通过皮肤的伤口愈合应用具有前景.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 药物输送系统 药物输送系统
背景情况:
- 氨酸是一种生物相容的聚合物,具有可调节的特性,因此适用于pH敏感的水凝.
- 响应pH的水凝为改善医疗治疗和加速愈合提供了潜力.
- 开发有效的凝矩阵系统用于药物输送仍然是复杂的.
研究的目的:
- 评估硫化氨酸水凝作为pH敏感药物递送系统.
- 在不同的pH环境下研究水凝的胀行为和药物释放动力学.
- 评估这些水凝在通过皮肤的伤口愈合应用中的潜力.
主要方法:
- 用于制造与脱乙基化脱糖化单位物理交叉连接的硫化 hialuronic 酸水凝.
- 封装低分子量德克斯坦作为模型药物.
- 在不同的pH值下研究水凝胀和药物释放概况.
主要成果:
- 水凝系统表现出可调节的药物释放特性,这取决于药物大小和pH值.
- 物理交叉连接策略导致了一个响应pH的矩阵.
- 该系统显示了封装化合物的受控释放的潜力.
结论:
- 硫化氨酸水凝表现出有希望的pH响应药物释放能力.
- 开发的水凝系统是智能药物输送的可行候选者,特别是在通过皮肤愈合的伤口中.
- 建议对各种模型药物进行进一步的研究,以充分阐明对pH反应的运输特性.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


